These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 26064978)
21. The sympathetic nervous system and obesity: role in aetiology and treatment. Snitker S; Macdonald I; Ravussin E; Astrup A Obes Rev; 2000 May; 1(1):5-15. PubMed ID: 12119646 [TBL] [Abstract][Full Text] [Related]
22. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Esler M; Rumantir M; Wiesner G; Kaye D; Hastings J; Lambert G Am J Hypertens; 2001 Nov; 14(11 Pt 2):304S-309S. PubMed ID: 11721888 [TBL] [Abstract][Full Text] [Related]
23. Can the metabolic syndrome be explained by a unifying concept? Hjemdahl P Lancet Diabetes Endocrinol; 2015 Feb; 3(2):96-8. PubMed ID: 25618291 [No Abstract] [Full Text] [Related]
24. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. Straznicky NE; Lambert EA; Lambert GW; Masuo K; Esler MD; Nestel PJ J Clin Endocrinol Metab; 2005 Nov; 90(11):5998-6005. PubMed ID: 16091482 [TBL] [Abstract][Full Text] [Related]
25. Sympathetic overactivity and cardiovascular disease in patients with chronic obstructive pulmonary disease (COPD). van Gestel AJ; Kohler M; Clarenbach CF Discov Med; 2012 Dec; 14(79):359-68. PubMed ID: 23272688 [TBL] [Abstract][Full Text] [Related]
26. Stress and its role in sympathetic nervous system activation in hypertension and the metabolic syndrome. Lambert EA; Lambert GW Curr Hypertens Rep; 2011 Jun; 13(3):244-8. PubMed ID: 21271362 [TBL] [Abstract][Full Text] [Related]
27. The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target? Lansdown A; Rees DA Clin Endocrinol (Oxf); 2012 Dec; 77(6):791-801. PubMed ID: 22882204 [TBL] [Abstract][Full Text] [Related]
28. The peripheral sympathetic nervous system in human obesity. van Baak MA Obes Rev; 2001 Feb; 2(1):3-14. PubMed ID: 12119635 [TBL] [Abstract][Full Text] [Related]
29. Autonomic dysregulation and the metabolic syndrome: pathologic partners in an emerging global pandemic. Lopes HF; Egan BM Arq Bras Cardiol; 2006 Oct; 87(4):538-47. PubMed ID: 17128327 [No Abstract] [Full Text] [Related]
30. Central mechanisms in sympathetic nervous dysregulation in obesity. Patel M; Braun J; Lambert G; Kameneva T; Keatch C; Lambert E J Neurophysiol; 2023 Dec; 130(6):1414-1424. PubMed ID: 37910522 [TBL] [Abstract][Full Text] [Related]
31. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome. Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):473-81. PubMed ID: 17451923 [TBL] [Abstract][Full Text] [Related]
32. Heart of the matter: coronary dysfunction in metabolic syndrome. Berwick ZC; Dick GM; Tune JD J Mol Cell Cardiol; 2012 Apr; 52(4):848-56. PubMed ID: 21767548 [TBL] [Abstract][Full Text] [Related]
33. Depressor effect by exercise training is associated with amelioration of hyperinsulinemia and sympathetic overactivity. Kohno K; Matsuoka H; Takenaka K; Miyake Y; Okuda S; Nomura G; Imaizumi T Intern Med; 2000 Dec; 39(12):1013-9. PubMed ID: 11197783 [TBL] [Abstract][Full Text] [Related]
34. Autonomic Regulation of Glucose Homeostasis: a Specific Role for Sympathetic Nervous System Activation. Carnagarin R; Matthews VB; Herat LY; Ho JK; Schlaich MP Curr Diab Rep; 2018 Sep; 18(11):107. PubMed ID: 30232652 [TBL] [Abstract][Full Text] [Related]
35. Sympathetic overactivity--the Cinderella of cardiovascular risk factors in dialysis patients. Vonend O; Rump LC; Ritz E Semin Dial; 2008; 21(4):326-30. PubMed ID: 18627567 [TBL] [Abstract][Full Text] [Related]